WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

CDE Annual Report Reveals Strong Growth and Evolving Focus in China's New Drug... The CDE has released its Annual Report on the Progress of Clinical Trials for New Drug Registration in China (2024), highlighting continued growth in trial activity, evol...
(6/19/2025)

Structuring Cross Border China Biotech 'NewCo'... (6/19/2025)

CDE Annual Report Reveals Strong Growth and Ev... (6/19/2025)

China Emerges as Prime Global Target for Multi... (6/17/2025)

China Proposes Shorter Clinical Trial Reviews ... (6/16/2025)

China's AI Healthcare Market (Part II): Opport... (6/12/2025)

China's AI Healthcare Market (Part I): Growth ... (6/12/2025)

Following FDA's Elsa, China Accelerates AI Hea... (6/9/2025)

China Ascends to Global Leadership in Oncology... (6/5/2025)

Mainland Chinese Market for Weight Loss and Di... (6/5/2025)

Driving Business Growth Through Investment Fun... (6/4/2025)

2025 Outlook for Medtech in China (Simon Kuche... (6/2/2025)

China's Clinical Trial Boom (Asimov Press) (5/22/2025)

Recent Executive Moves (6/20/2025) CDE Solicits Comments on the Draft ICH ... (6/20/2025) CDE Solicits Comments on the Draft ICH... (6/20/2025) CDE Issues the Technical Guidelines for ... (6/20/2025) MindRank's Oral GLP-1RA MDR-001 Achieves... (6/20/2025) Simcere Gains Approval to Market Insomni... (6/20/2025) Lepu Begins MRG007 Trial in China, Licen... (6/20/2025) CanSinoBIO Obtained NDA Approval for its... (6/20/2025) China Set to Revive Biotech IPOs for Unp... (6/19/2025) China Becomes Testing Ground for Weight-... (6/19/2025) Chinese Biopharma Firms Reroute Supply C... (6/19/2025) China's Biotech Boom Forces U.S. Pharma ... (6/19/2025) CDE Solicits Comments on the Application... (6/19/2025) CDE Solicits Comments on the Draft Techn... (6/19/2025) GenMedicn Secures Series B Funding to F... (6/18/2025) FDA Clears Boan Biotech to Advance Innov... (6/18/2025) EpimAb's HKEX IPO Application Accepted, ... (6/18/2025) Abbisko Launches Pivotal Irpagratinib Tr... (6/18/2025)

NH's DB6: China's Consumer Healthcare Market Underperfo... China's Hospital Drug Market Shows Slight Growth in 202... China Unveils Ambitious Plan to Boost Health-Related Co... Chinese VMS OTC Market Growth Slowed to 2.7% in 2024 Newish Tech Secures Series B Financing to Advance Next-...

China's Biotech Boom Forces U.S. Pharma to Weigh Innova... Chinese Biopharma Firms Reroute Supply Chains and R\&D ... China Becomes Testing Ground for Weight-Loss Drugs Desp... China Set to Revive Biotech IPOs for Unprofitable Start... EpimAb's HKEX IPO Application Accepted, Prospectus Now ...

CDE Issues the Technical Guidelines for IVRT and IVPT o... CDE Solicits Comments on the Draft ICH Guideline E21:... CDE Solicits Comments on the Draft ICH Guideline E21: ... CDE Solicits Comments on the Draft Technical Guidelines... CDE Solicits Comments on the Application Dossier Requir...

China Issues 2025 Action Plan to Combat Malpractice in... NHSA Issues Notice to Enhance Drug Pricing and Procurem... China's Child Health Improves: NHC Official China Expands Geriatric Services at Major Hospitals as ... China's BMI Fund Reports Big Surplus in Q1/2025

Tianjin Slaps CNY 362M Fine for Drug Price-Fixing Sche... Gavi Launches $224M Arbitration Claim Against Clover Bi... AstraZeneca Faces Escalating Legal Challenges in China ... BeiGene Secures Key Patent Victory in Brukinsa Dispute ... State Council Approves Draft Medical Security Law, Stre...

FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ... Aurobindo Challenges China in the Global Penicillin G M...

CanSinoBIO Obtained NDA Approval for its 13-Valent Pneu... Lepu Begins MRG007 Trial in China, Licenses Global Righ... Simcere Gains Approval to Market Insomnia Drug Quviviq ... MindRank's Oral GLP-1RA MDR-001 Achieves Promising Phas... Abbisko Launches Pivotal Irpagratinib Trial Targeting F...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Former CFDA Commissioner Bi Jingquan Under Investigati... Recent Official and Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...